Loading…
Godavari Biorefineries (GODAVARIB)₹223.87−1.34%Diversified FMCG
In the Jun 2026 quarter (consolidated), Godavari Biorefineries reported sales of ₹559 Cr, up 4.7% from Jun 2025, and net profit of −₹18.99 Cr. For the year to Mar 2026, sales were ₹1,990 Cr and net profit ₹3.99 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 239 | 398 | 616 | 523 | 321 | 447 | 581 | 534 | 431 | 460 | 565 | 559 |
| Expenses | 271 | 353 | 501 | 535 | 354 | 411 | 467 | 527 | 439 | 417 | 477 | 557 |
| Operating Profit | −32.09 | 45.12 | 114 | −12.03 | −33.11 | 36.10 | 112 | 6.02 | −8.03 | 43.14 | 86.19 | 1.01 |
| OPM % | −13.1% | 11.0% | 17.9% | −2.3% | −10.0% | 8.0% | 19.0% | 1.1% | −1.8% | 9.0% | 14.9% | 0.1% |
| Other Income | 1.01 | 2.01 | 11.02 | 3.01 | 1.01 | 4.01 | 9.01 | 1.01 | −23.04 | −6.01 | 9.03 | 2.01 |
| Interest | 20.04 | 18.02 | 20.02 | 20.03 | 20.04 | 19.05 | 13.03 | 15.03 | 12.02 | 10.02 | 11.02 | 14.03 |
| Depreciation | 15.03 | 16.04 | 14.02 | 13.03 | 12.02 | 12.02 | 13.02 | 14.02 | 14.04 | 14.02 | 14.03 | 14.02 |
| Profit before tax | −64.96 | 12.99 | 91.05 | −42.03 | −64.03 | 8.01 | 96.06 | −22.01 | −57.02 | 13.01 | 69.99 | −25.98 |
| Tax % | 0.0% | −200.9% | 28.1% | −36.9% | 17.1% | 32.1% | 25.1% | −27.9% | −26.9% | 39.1% | 25.1% | −24.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −26.49 | −4.81 | 2.54 | 0.00 |
| Net Profit | −64.91 | 37.96 | 64.96 | −25.97 | −74.93 | 5.99 | 71.88 | −15.97 | −41.98 | 7.99 | 52.91 | −18.99 |
| EPS (Rs) | −15.52 | 9.14 | 15.53 | −6.22 | −17.84 | 1.12 | 14.04 | −3.12 | −8.12 | 1.60 | 10.32 | −3.77 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,461 | 1,540 | 1,704 | 2,017 | 1,689 | 1,872 | 1,990 | 2,014 |
| Expenses | 1,355 | 1,379 | 1,568 | 1,866 | 1,553 | 1,766 | 1,859 | 1,891 |
| Operating Profit | 103 | 159 | 134 | 147 | 134 | 104 | 127 | 122 |
| OPM % | 7.0% | 9.9% | 8.0% | 7.0% | 8.0% | 6.0% | 6.0% | 6.1% |
| Other Income | 14.04 | 8.02 | 6.01 | 7.01 | 14.03 | 16.03 | −19.05 | −18.01 |
| Interest | 69.10 | 72.16 | 60.06 | 73.11 | 76.07 | 72.15 | 49.09 | 47.09 |
| Depreciation | 45.08 | 47.07 | 48.12 | 50.06 | 60.10 | 50.07 | 54.10 | 56.11 |
| Profit before tax | 3.01 | 45.96 | 31.99 | 31.98 | 12.01 | −2.01 | 4.99 | 0.00 |
| Tax % | −23.9% | 41.1% | 40.1% | 38.1% | 1.0% | 1,421.1% | 23.1% | — |
| Exceptional items | 3.99 | 0.99 | 0.00 | −0.99 | 0.00 | 0.99 | −29.97 | −28.76 |
| Net Profit | 3.99 | 26.98 | 18.98 | 19.99 | 11.99 | −22.96 | 3.99 | −0.07 |
| EPS (Rs) | 0.96 | 6.46 | 4.54 | 4.67 | 2.92 | −4.56 | 0.68 | 0.03 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 42.18 | 42.17 | 42.19 | 42.18 | 42.16 | 51.20 | 51.23 |
| Reserves | 385 | 412 | 431 | 449 | 459 | 732 | 738 |
| Borrowings | 590 | 570 | 636 | 737 | 655 | 490 | 532 |
| Other Liabilities | 420 | 421 | 628 | 520 | 840 | 686 | 737 |
| Total Liabilities | 1,437 | 1,445 | 1,737 | 1,749 | 1,997 | 1,959 | 2,058 |
| Fixed Assets | 737 | 710 | 668 | 868 | 852 | 864 | 888 |
| CWIP | 17.07 | 9.03 | 50.19 | 17.07 | 29.11 | 37.14 | 129 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 684 | 727 | 1,018 | 862 | 1,116 | 1,057 | 1,040 |
| Inventories | 384 | 425 | 654 | 520 | 807 | 741 | 777 |
| Trade receivables | 126 | 169 | 173 | 202 | 191 | 138 | 114 |
| Cash & equivalents | 44.19 | 40.19 | 47.20 | 45.21 | 33.13 | 31.13 | 32.11 |
| Total Assets | 1,437 | 1,445 | 1,737 | 1,749 | 1,997 | 1,959 | 2,058 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 249 | 130 | 44.85 | 196 | 185 | 5.98 | 171 |
| Cash from investing activity | −22.93 | −6.98 | −47.87 | −213 | −43.86 | −68.82 | −163 |
| Cash from financing activity | −225 | −121 | 5.98 | 27.92 | −151 | 63.82 | −5.98 |
| Net cash flow | 0.99 | 1.99 | 2.99 | 10.98 | −9.98 | 0.99 | 2.99 |
| Capex | 26.01 | 12.02 | 50.01 | 217 | 55.04 | 72.13 | 169 |
| Free cash flow | 223 | 119 | −4.99 | −19.97 | 130 | −64.92 | 5.99 |
| CFO / OP % | 242.0% | 82.0% | 34.0% | 135.0% | 140.0% | 6.0% | 136.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 30 | 39 | 36 | 36 | 40 | 26 | 20 |
| Inventory days | 130 | 146 | 200 | 137 | 250 | 195 | 198 |
| Days payable | 124 | 133 | 177 | 106 | 196 | 141 | 147 |
| Cash conversion cycle | 39 | 55 | 61 | 68 | 95 | 82 | 74 |
| Working capital days | −68 | 1 | 3 | 2 | −14 | 21 | 16 |
| ROCE % | — | 12.0% | 9.0% | 9.0% | 7.0% | 6.0% | 7.0% |
For the Jun 2026 quarter, Godavari Biorefineries reported sales of ₹559 Cr, up 4.7% year on year and net profit of −₹18.99 Cr. The operating margin was 0.1%.
Godavari Biorefineries' sales for the year to Mar 2026 were ₹1,990 Cr; over the last twelve months they were ₹2,014 Cr.
Net profit for the year to Mar 2026 was ₹3.99 Cr, and −₹0.07 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.03.
Godavari Biorefineries reported borrowings of ₹532 Cr at Mar 2026, against cash and equivalents of ₹32.11 Cr.
Cash from operations was ₹171 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹5.99 Cr.